← 홈

위암

143개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 143개
ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Docetaxel, Capecitabine, Cisplatin, Bevacizumab (Docetaxel, Capecitabine, Cisplatin, Bevacizumab)

Advanced Gastric Cancer · Advanced Gastric Cancer

#AdvancedGastricCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, Leucovorin (Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, Leucovorin)

Stomach Neoplasms; Esophageal Neoplasms · Stomach Neoplasms

#StomachNeoplasms#Antibody#Phase2#항체#면역항체+3
효능 ORR 85%임상시험 1상태 ACTIVE
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

trastuzumab (Herceptin, Docetaxel, Leukvorin, Flurouracil, Cisplatin, Trastuzumab)

Gastroesophageal Junction Adenocarcinoma; Gastric Cancer · Gastroesophageal Junction Adenocarcinoma

#GastroesophagealJunctionAdenocar#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab (Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab)

Metastatic Gastric Cancer; Adenocarcinoma of the Gastro-oesophageal Junction · Metastatic Gastric Cancer

#MetastaticGastricCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

trastuzumab (Herceptin, Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab)

Metastatic Gastric Cancer; Adenocarcinoma of the Gastro-oesophageal Junction · Metastatic Gastric Cancer

#MetastaticGastricCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Docetaxel, Oxaliplatin, S-1 and Durvalumab)

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma · Resectable Gastric or Gastroesophageal J

#ResectableGastricorGastroesophag#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAkesoPhase 2

Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine (Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting CLDN18.2 and PD-L1 CAR-T cells (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

Advanced Solid Tumor · PD-L1

#PD-L1#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

CLDN18.2 + MUC1 (EB-DNK102 dual-targeting CAR-NK cells, EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1))

Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Disease · CLDN18.2

#CLDN182#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
ADCBiologicstaleElevation OncologyPhase 1

EO-3021 (EO-3021)

Stomach Neoplasm; Gastrointestinal Neoplasms · Stomach Neoplasm

#StomachNeoplasm#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 1%임상시험 1상태 DISCONTINUED
CGTBiologicstaleSinobioway Cell Therapy Co., Lt…Preclinical

EPCAM-targeted CAR-T cells (EPCAM-targeted CAR-T cells)

Stomach Neoplasms · Liver Neoplasms

#LiverNeoplasms#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleInstitut für Klinische Krebsfor…Phase 3

trastuzumab (Herceptin, FLOT + Herceptin/Pertuzumab)

Stomach Cancer; Gastroesophageal Junction Cancer · Stomach Cancer

#StomachCancer#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Herceptin+XELOX)

Metastatic or Recurrent Gastric Adenocarcinoma; Her-2 Positive Gastric Cancer · Metastatic or Recurrent Gastric Adenocar

#MetastaticorRecurrentGastricAden#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleIksuda Therapeutics Ltd.Phase 1

IKS014 (IKS014)

Breast Cancer; Gastric Cancer · Breast Cancer

#BreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Runshi Pharmaceutical …Phase 2

Irinotecan liposomes (Irinotecan liposomes)

Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma; Expressing Human E… · Localized Advanced or Metastatic Gastric

#LocalizedAdvancedorMetastaticGas#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 32%임상시험 1상태 RECRUITING
AntibodystaleM.D. Anderson Cancer CenterPhase 1

LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide (LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide)

Metastatic Esophageal; Gastric Cancer · Metastatic Esophageal

#MetastaticEsophageal#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleM.D. Anderson Cancer CenterPhase 1

LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide (LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide)

Metastatic Esophageal; Gastric Cancer · Metastatic Esophageal

#MetastaticEsophageal#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleUniversity of Kansas Medical Ce…Phase 2

pembrolizumab (Keytruda, Neoadjuvant Treatment - mFOLFOX6 & Pembrolizumab)

Gastro Esophageal Junction Cancer; Stomach Cancer · Gastro Esophageal Junction Cancer

#GastroEsophagealJunctionCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleFox Chase Cancer CenterPhase 1

Neratinib Pill (Neratinib Pill)

Gastric Cancer; Gastrointestinal Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING

5 / 8 페이지

← 이전다음 →